Causes and Management of Hyperkyphosis

Khaled Nasser Almujel

Almajmaah university, Saudi Arabia.

Abdalah Emad Almhmd

Almajmaah university, Saudi Arabia.

Abdulrahman Arshed N. Alharfy

University of Tabuk, Saudi Arabia.

Ibrahim Abdullah Said Albalawi

University of Tabuk, Saudi Arabia.

Tariq Bander F. Alanazi

University of Tabuk, Saudi Arabia.

Aysha Jaber Alshehri

University of Tabuk, Saudi Arabia.

Bedour Eid H. Alatawi *

University of Tabuk, Saudi Arabia.

Abdullah Dhafer Alshehri

University of Tabuk, Saudi Arabia.

Meshari Salman Alhawiti

University of Tabuk, Saudi Arabia.

Shumoukh Homoud Alshehri

University of Tabuk, Saudi Arabia.

*Author to whom correspondence should be addressed.


Abstract

Hyperkyphosis is identified when kyphosis angle exceeds the normal ranges. In overall, hyperkyphosis upsurges with age, particularly after the age of 40. It arises as a consequence of multifactorial causes and is associated with increased health susceptibility. Separately from the penalties of typical aging, as declining muscle power and degenerative vicissitudes of the spine, additional influences lead to the growth of the kyphosis angle. Besides fractures, other adverse health outcomes associated with hyperkyphosis include worsening physical function, falls and earlier mortality. Given the growing older population and the high prevalence of age-related hyperkyphosis, better delineation of associated ill-health outcomes will help inform the development and testing of effective kyphosis managements. The sequence of handling with kyphosis start conventional and rolling to surgical interference as a previous option if the patient’s symptoms do not recover with conventional treatment or if the curving is too significant.

Keywords: kyphosis, hyperkyphosis, aging, causes, management


How to Cite

Almujel, K. N., Almhmd, A. E., Alharfy, A. A. N., Albalawi, I. A. S., Alanazi, T. B. F., Alshehri, A. J., Alatawi, B. E. H., Alshehri, A. D., Alhawiti, M. S. and Alshehri, S. H. (2021) “Causes and Management of Hyperkyphosis”, Journal of Pharmaceutical Research International, 33(35B), pp. 1–8. doi: 10.9734/jpri/2021/v33i35B31892.